Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items
Powering up public support for electric vehicles
Tackling greenhouse gas emissions will only work if public support for action remains strong. That means ensuring tangible improvements in people’s lives and heading off any brewing backlash.Assessing the economy
Over the past few days and weeks, there has been lots of rather histrionic commentary about the UK’s economic situation as if the budget has created an economic disaster from which we’ll never recover.Towards a UK trade strategy
The UK is facing a precarious and volatile period for global trade.